Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Andrea Pawellek et al
demonstrating an in vivo effect of HAMNO as an inhibitor of RPA32 phosphorylation by ATR
343(2):239-48
Tenofovir Disoproxil Fumarate administration is safe and effective in the woodchuck model of chronic HBV infection
136(3):1038-48
BIBS 39 odoHoechst 33258 Andrea Pawellek et alBIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist. Target: Angiotensin Receptorin vitro: BIBS 39 displaces [125I] AII from its specific binding sites with a Ki value of 29 7 nM for the AII subtype 1 (AT1) receptor and a Ki value of 480 110 nM for the AII subtype 2 (AT2) receptor. BIBS 222 shows a Ki value of 20 7 nM for the AT1 subtype and a Ki value of 730 170 nM for the AT2 subtype. BIBS 39 is 17 times more selective for the AT1
US$ 95.55
US$ 836.00
US$ 84.95
US$ 19686.00
US$ 18.45
US$ 13.20
US$ 131.72
US$ 119.85
US$ 301.55
US$ 1223.95
US$ 432.60
US$ 121.50
US$ 15.00
US$ 64.95
US$ 193.40